The Public Health Commission, in which the autonomous communities and the Ministry of Health are represented, has agreed that children between 5 and 11 years old whowho are infected before receiving the COVID-19 vaccine they will receive a single dose from 8 weeks after the diagnosis of the infection.
This new update of the Vaccination Strategy establishes that if the infection is diagnosed after the first dose, the second dose will be administered from 8 weeks after the diagnosis of the infection, maintaining the interval of 8 weeks with respect to the first dose.
Likewise, the update includes that in people who received the complete vaccination schedule who later have symptomatic or asymptomatic infection by SARS-CoV-2, the interval between infection and administration of the booster dose It will be for a minimum of 4 weeks, but, in any case, its administration is recommended 5 months after the diagnosis of the infection.
“Current evidence shows that the fact of having a SARS-CoV-2 infection after having the complete primary vaccination schedule causes the development of a stronger immune response and broader in terms of neutralizing other variants of the virus, compared to the immune response observed in people who only suffered infection or who only received two doses”, justifies the Ministry of Health.
In addition, they explain that omicron infections “increase the response of memory cells to different viral antigens to protein S compared to post-vaccination infections caused by the Delta variant, implying a broadening of immunity.